Northern Trust
MLTX icon

Northern Trust’s MoonLake Immunotherapeutics MLTX Stock Holding History

Northern Trust’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$363K Buy
19,477
+998
+5% +$16.5K ﹤0.01% 3737
2025
Q4 		$244K Sell
18,479
-26,536
-59% -$313K ﹤0.01% 3911
2025
Q3 		$323K Buy
45,015
+30,701
+214% +$1.6M ﹤0.01% 3802
2025
Q2 		$676K Sell
14,314
-17
-0.1% -$693 ﹤0.01% 3551
2025
Q1 		$560K Buy
14,331
+70
+0.5% +$3.02K ﹤0.01% 3530
2024
Q4 		$772K Buy
14,261
+8,811
+162% +$450K ﹤0.01% 3503
2024
Q3 		$275K Buy
5,450
+573
+12% +$26.9K ﹤0.01% 3774
2024
Q2 		$214K Sell
4,877
-837
-15% -$35.5K ﹤0.01% 3846
2024
Q1 		$287K Sell
5,714
-1,488
-21% -$80.7K ﹤0.01% 3760
2023
Q4 		$435K Buy
7,202
+1,465
+26% +$75.5K ﹤0.01% 3581
2023
Q3 		$327K Buy
+5,737
New +$317K ﹤0.01% 3635

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return